Eslam Katab, PhD, currently serves as a Global Clinical Development Manager (Biosimilars) at Sandoz since February 2024. Prior to this role, Eslam was a Global Patient Safety Scientist at MorphoSys from July 2022 to January 2024 and conducted research at the Technical University of Munich as a Research Scientist between September 2018 and July 2022. Eslam's experience includes a visiting researcher position at the Max Planck Institute of Biochemistry, research associate work at the Gene Center Munich, and a master's thesis focused on pediatric tumor immunology at Helmholtz Zentrum München. Earlier roles included an internship at LMU Klinikum München and a position as a Product Specialist at Coloplast. Eslam holds a PhD in Experimental Medicine and a Master’s Degree in Biology/Biological Sciences with a focus on Immunology, as well as a Bachelor's Degree in Pharmaceutical Sciences from Cairo University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices